Latest ankylosing spondylitis Stories
The expression of a transporter protein called the Breast Cancer Resistance Protein (BCRP) in rheumatoid arthritis (RA) patients may indicate higher disease activity and could be a barrier to the effectiveness of disease-modifying antirheumatic drugs (DMARDs).
WILMINGTON, Del., April 30 /PRNewswire-FirstCall/ -- AstraZeneca and POZEN Inc. today announced the U.S.
MOUNTAIN VIEW, Calif., March 24 /PRNewswire/ -- Axis Surgical Technologies, Inc., reports the first evaluation of the C-MOR(TM) Visualization Device in a spine procedure.
Work done in part by researchers at The University of Texas Health Science Center at Houston has led to the discovery of two new genes that are implicated in ankylosing spondylitis (AS), an inflammatory and potentially disabling disease.
Genomic switches can predispose an individual to one set of autoimmune disorders but protect the same person against another set of them, scientists at Stanford University School of Medicine have found.
PHILADELPHIA, Oct. 19 /PRNewswire-FirstCall/ -- AstraZeneca (NYSE: AZN) and POZEN Inc.
HORSHAM, Pa. and KENILWORTH, N.J., Oct. 6 /PRNewswire/ -- Centocor Ortho Biotech Inc.
Chinese patients will soon have the opportunity to take part in a study of a novel therapy aimed at reversing the autoimmune disease, ankylosing spondylitis.
The risk of tuberculosis for patients who take arthritis drugs differs from that of the French population at large depending on the agent used, researchers say. Treatment with anti-tumor necrosis factor agents is recognized as a risk factor for TB in patients with immune-mediated inflammatory diseases such as rheumatoid arthritis, ankylosing spondylitis, Crohn's disease, psoriatic arthritis and psoriasis.
Positive Opinion Recommends Approval of New Anti-TNF Therapy in Three Rheumatic Diseases with Novel SmartJect(TM) Autoinjector HORSHAM, Pa. and KENILWORTH, N.J., June 26 /PRNewswire-FirstCall/ -- Centocor Ortho Biotech Inc.
- Growing in low tufty patches.